Potential Dilution from the Exercise of Stock Acquisition Rights
First written in FY2019. 6 of 13 entries say "Materialised", first in FY2020-Q1. Latest entry: FY2026-H1.
Living Technologies moved to the "Worse" side of this theme in 2026, 5 years after the typical company in this theme (2021).
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
56 other companies' latest entry also says "Materialised".
- FY2026-H1MaterialisedAnnual report
「1 October 2025–31 December 2025 (Note) 1 1,740 1,345,484 (Note) 1. The increase resulted from the exercise of stock acquisition rights.」
The number of shares increased by 1,740 during the current interim consolidated accounting period as a result of the exercise of stock acquisition rights. The interim securities report also states that there were no applicable matters concerning the stock option plan or other stock acquisition rights. - FY2024MitigatedAnnual report
「As of the end of the month preceding the submission date of this document, the number of potential shares represented by these stock acquisition rights was 1,896, equivalent to 0.1% of the total number of shares issued, 1,343,588.」
The number of potential shares decreased from 2,124, or 0.2%, in the previous disclosure to 1,896, or 0.1%, reducing the disclosed scale of the potential for dilution. - FY2023MitigatedAnnual report
「As of the end of the month preceding the submission date of this document, the number of potential shares represented by these stock acquisition rights was 2,124, equivalent to 0.2% of the total number of shares issued, 1,343,588.」
The number of potential shares represented by stock acquisition rights decreased from 15,124, or 1.1%, in the previous disclosure to 2,124, or 0.2%, reducing the disclosed scale of the potential for dilution. - FY2023-Q3MaterialisedAnnual report
「1 April 2023–30 June 2023 (Note) 100 1,343,588 34 194,295 34 163,295 (Note) The increase resulted from the exercise of stock acquisition rights.」
The number of shares increased by 100 in the third-quarter accounting period as a result of the exercise of stock acquisition rights, bringing the total number of shares issued to 1,343,588. - FY2022MitigatedAnnual report
「As of the end of the month preceding the submission date of this document, the number of potential shares represented by these stock acquisition rights was 15,124, equivalent to 1.1% of the total number of shares issued, 1,343,488.」
The number of potential shares decreased from 16,380, or 1.2%, in the previous fiscal year to 15,124, or 1.1%. The potential for dilution remains, but the disclosed scale has declined. - FY2022-Q3MaterialisedAnnual report
「1 April 2022–30 June 2022 (Note) 1,244 1,343,488 431 194,260 431 163,260 (Note) The increase resulted from the exercise of stock acquisition rights.」
The number of shares increased by 1,244 in the third-quarter accounting period as a result of the exercise of stock acquisition rights, bringing the total number of shares issued to 1,343,488. - FY2021WorsenedAnnual report
「As of the end of the month preceding the submission date of this document, the number of potential shares represented by these stock acquisition rights was 16,380, equivalent to 1.2% of the total number of shares issued, 1,342,244.」
The number of potential shares represented by stock acquisition rights increased from 5,948, or 0.4%, in the previous fiscal year to 16,380, or 1.2%. - FY2021-Q3MaterialisedAnnual report
「1 April 2020–30 June 2020 (Note) 2,232 1,342,244 381 193,829 381 162,829 (Note) Increase due to the exercise of share acquisition rights.」
During the third quarter accounting period, 2,232 shares were added through the exercise of share acquisition rights, bringing total shares issued to 1,342,244. - FY2021-Q1WorsenedAnnual report
「Number of share acquisition rights 40 Common shares 4,000 shares Potential shares from this issuance 9,500 shares (100 shares per share acquisition right)」
As a material subsequent event, the company disclosed the resolution to issue 4,000 shares under the sixth series of share acquisition rights and 9,500 shares under the seventh series, creating the potential for additional shares. - FY2020MitigatedAnnual report
「As of the end of the month preceding the filing date of this document, the number of potential shares represented by these share acquisition rights was 5,948, equivalent to 0.4% of the total 1,340,012 shares issued.」
The number of potential shares declined from 15,596 shares, or 1.2%, disclosed for the previous fiscal year to 5,948 shares, or 0.4%. During the current fiscal year, 6,412 shares were issued through the exercise of share acquisition rights. - FY2020-Q3MaterialisedAnnual report
「1 April 2020–30 June 2020 (Note) 5,980 1,339,980 896 193,436 896 162,436 (Note) Increase due to the exercise of share acquisition rights.」
During the third quarter accounting period, 5,980 shares were added through the exercise of share acquisition rights, bringing total shares issued to 1,339,980 and share capital to ¥193.436 million. - FY2020-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
From October to December 2019, 400 shares were added through the exercise of share acquisition rights, bringing total shares issued to 1,334,000. The existing dilution risk materialized as an actual share issuance. - FY2019First statedAnnual report
「As of the end of the month preceding the filing date of this document, the number of potential shares represented by these share acquisition rights was 15,596, equivalent to 1.2% of the total 1,333,600 shares issued.」
The document disclosed 15,596 potential shares from the exercise of stock options, representing potential dilution equivalent to 1.2% of total shares issued.